The Real Clinical Background of Advanced Colorectal Cancer Treatment Situation Survey (Sprit)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government.
Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01549067
Verified March 2012 by Lin Shen，MD & Ruihua Xu，MD、PhD, Chinese Medical Doctor Association. Recruitment status was: Recruiting
: March 8, 2012
Last Update Posted
: March 14, 2012
Chinese Medical Doctor Association
Information provided by (Responsible Party):
Lin Shen，MD & Ruihua Xu，MD、PhD, Chinese Medical Doctor Association
Collect the real clinical background of advanced colorectal cancer c of China.
Condition or disease
Advanced Malignant NeoplasmColorectal Cancer
The Primary Objectives of this study is collect the real clinical background of advanced colorectal cancer treatment situation of China. The Secondary Objectives is the mutation of K-ras , targeting therapy , use present situation of cetuximab and liver metastases treatment situation of colorectal cancer patients.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study:
Child, Adult, Senior
Sexes Eligible for Study:
Accepts Healthy Volunteers:
Advanced Colorectal Cancer
Patients with histologically or cytologically confirmed diagnosis of metastatic colorectal cancer.
Patients with histologically or cytologically confirmed diagnosis other than metastatic colorectal cancer.